Barrett Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.71M | Buy |
14,222
+39
| +0.3% | +$10.2K | 0.16% | 71 |
|
|
2021
Q4 | $3.12M | Sell |
14,183
-14,427
| -50% | -$3.17M | 0.12% | 76 |
|
|
2021
Q3 | $5.19M | Sell |
28,610
-872
| -3% | -$158K | 0.24% | 64 |
|
|
2021
Q2 | $5.94M | Sell |
29,482
-10,199
| -26% | -$2.06M | 0.27% | 59 |
|
|
2021
Q1 | $8.53M | Buy |
39,681
+5,420
| +16% | +$1.16M | 0.42% | 51 |
|
|
2020
Q4 | $8.1M | Sell |
34,261
-8,384
| -20% | -$1.98M | 0.42% | 49 |
|
|
2020
Q3 | $11.6M | Buy |
42,645
+16,863
| +65% | +$4.59M | 0.68% | 43 |
|
|
2020
Q2 | $7.49M | Buy |
25,782
+14,467
| +128% | +$4.2M | 0.48% | 47 |
|
|
2020
Q1 | $2.69M | Buy |
+11,315
| New | +$2.69M | 0.21% | 65 |
|
|
2019
Q4 | – | Sell |
-145
| Closed | -$25K | – | 383 |
|
|
2019
Q3 | $25K | Sell |
145
-45
| -24% | -$7.76K | ﹤0.01% | 274 |
|
|
2019
Q2 | $35K | Hold |
190
| – | – | ﹤0.01% | 256 |
|
|
2019
Q1 | $35K | Hold |
190
| – | – | ﹤0.01% | 260 |
|
|
2018
Q4 | $31K | Buy |
+190
| New | +$31K | ﹤0.01% | 263 |
|
|
2016
Q2 | – | Sell |
-165
| Closed | -$13K | – | 394 |
|
|
2016
Q1 | $13K | Buy |
+165
| New | +$13K | ﹤0.01% | 304 |
|